1. Home
  2. NDLS vs HRTX Comparison

NDLS vs HRTX Comparison

Compare NDLS & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Noodles & Company

NDLS

Noodles & Company

N/A

Current Price

$13.80

Market Cap

68.7M

ML Signal

N/A

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.36

Market Cap

61.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NDLS
HRTX
Founded
1995
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.7M
61.2M
IPO Year
2013
2007

Fundamental Metrics

Financial Performance
Metric
NDLS
HRTX
Price
$13.80
$0.36
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
20.4K
★ 1.8M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $495,089,000.00
$154,904,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
0.37
★ 7.36
52 Week Low
$0.47
$0.26
52 Week High
$19.00
$1.58

Technical Indicators

Market Signals
Indicator
NDLS
HRTX
Relative Strength Index (RSI) 47.25 49.48
Support Level $12.83 $0.30
Resistance Level $13.95 $0.34
Average True Range (ATR) 0.68 0.02
MACD 0.07 0.00
Stochastic Oscillator 66.04 75.62

Price Performance

Historical Comparison
NDLS
HRTX

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services. It is focused on offering customers flavorful, cooked-to-order dishes in a warm and welcoming environment at an attractive value. It has approximately 340 company-owned restaurants and 83 franchise restaurants in 31 states.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: